Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
CALL
Wolfspeed
WOLF
$1.62B
| $15.8M | 0.01% |
266,800
+78,100
| +41% | +$3.76M |
|
1602
PUT
XPO
XPO
$24.7B
| $15.8M | 0.01% |
590,712
+44,817
| +8% | +$1.07M |
|
1603
PUT
Bath & Body Works
BBWI
$3.89B
| $15.7M | 0.01% |
1,301,200
-194,333
| -13% | -$2.17M |
|
|
GRMN
1604
CALL
Garmin
GRMN
$60.1B
| $15.7M | 0.01% |
161,200
+24,900
| +18% | +$2.13M |
|
1605
Essex Property Trust
ESS
$18.4B
| $15.7M | 0.01% |
68,564
+3,075
| +5% | +$737K |
|
1606
Trex
TREX
$5.04B
| $15.7M | 0.01% |
241,520
+154,160
| +176% | +$8.22M |
|
1607
PUT
Zimmer Biomet
ZBH
$19.2B
| $15.7M | 0.01% |
135,342
+56,341
| +71% | +$6.49M |
|
1608
Scotiabank
BNS
$111B
| $15.7M | 0.01% |
379,293
-78,616
| -17% | -$3.14M |
|
1609
Ciena
CIEN
$60.2B
| $15.7M | 0.01% |
289,171
-70,320
| -20% | -$3.5M |
|
1610
Petrobras
PBR
$116B
| $15.7M | 0.01% |
1,893,448
-101,050
| -5% | -$732K |
|
1611
Intellia Therapeutics
NTLA
$1.66B
| $15.6M | 0.01% |
744,427
-152,610
| -17% | -$2.59M |
|
1612
CALL
Martin Marietta Materials
MLM
$33B
| $15.6M | 0.01% |
75,700
-24,000
| -24% | -$4.61M |
|
1613
PUT
Yeti Holdings
YETI
$3.38B
| $15.6M | 0.01% |
365,800
+178,600
| +95% | +$5.37M |
|
1614
Brink's
BCO
$4.72B
| $15.6M | 0.01% |
343,147
+304,587
| +790% | +$13.9M |
|
1615
Wingstop
WING
$3.37B
| $15.6M | 0.01% |
112,306
+2,208
| +2% | +$257K |
|
|
BAND
1616
Bandwidth Inc
BAND
$1.73B
| $15.6M | 0.01% |
122,835
+68,003
| +124% | +$6.86M |
|
1617
PUT
Emerson Electric
EMR
$91B
| $15.6M | 0.01% |
251,200
+90,700
| +57% | +$5.15M |
|
1618
Principal Financial Group
PFG
$24.5B
| $15.6M | 0.01% |
374,973
+265,499
| +243% | +$9.69M |
|
|
CBPO
1619
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $15.6M | 0.01% |
152,200
-6,200
| -4% | -$663K |
|
|
SGEN
1620
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $15.5M | 0.01% |
91,500
+46,700
| +104% | +$6.97M |
|
1621
PUT
Enphase Energy
ENPH
$5.31B
| $15.5M | 0.01% |
326,400
-172,700
| -35% | -$8.25M |
|
1622
CALL
ON Semiconductor
ON
$31.9B
| $15.5M | 0.01% |
781,100
+287,400
| +58% | +$4.68M |
|
|
1623
CALL
Baxter International
BAX
$13.8B
| $15.5M | 0.01% |
179,600
+34,600
| +24% | +$3.01M |
|
1624
Buckle
BKE
$2.28B
| $15.5M | 0.01% |
986,127
+158,953
| +19% | +$2.38M |
|
1625
Syndax Pharmaceuticals
SNDX
$1.74B
| $15.4M | 0.01% |
1,041,580
+1,028,435
| +7,824% | +$15.7M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.